Vivos Therapeutics, Inc.

VVOS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$6,260$1,643$3,519$24,030
Short-Term Investments$0$0$0$0
Receivables$430$202$457$1,719
Inventory$0$0$0$0
Other Curr. Assets$783$616$1,448$1,575
Total Curr. Assets$7,473$2,461$5,424$27,324
Property Plant & Equip (Net)$4,382$4,699$4,777$2,825
Goodwill$2,843$2,843$2,843$2,843
Intangibles$370$420$302$341
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$216$307$374$356
Total NC Assets$7,811$8,269$8,296$6,365
Other Assets$0$0$0$0
Total Assets$15,284$10,730$13,720$33,689
Liabilities
Payables$1,098$2,145$1,411$920
Short-Term Debt$477$948$838$1,334
Tax Payable$481$327$0$0
Deferred Revenue$896$2,138$2,926$2,399
Other Curr. Liab.$2,026$1,731$1,638$2,856
Total Curr. Liab.$4,978$7,289$6,813$7,509
LT Debt$1,035$1,521$1,994$298
Deferred Rev, NC$97$289$112$0
Deferred Tax Liab, NC$0$0-$112$0
Other NC Liab.$1,220$1,220$112$343
Total NC Liab.$2,352$3,030$2,106$641
Other Liabilities$0$0$0$0
Cap. Leases$1,512$1,995$2,413$69
Total Liabilities$7,330$10,319$8,919$8,150
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$2$2
Retained Earnings-$104,187-$93,051-$79,468-$55,623
AOCI$0$0$0$0
Other Equity$112,141$93,462$84,267$81,160
Total Equity$7,954$411$4,801$25,539
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,284$10,730$13,720$33,689
Net Debt-$4,748$826-$687-$22,398